Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Serum Institute allowed to export 5 crore Covovax doses to Indonesia

Ruchika Sharma16 Nov 2021 5:30 AM

New Delhi: The Indian government has permitted export of 5 crore doses of Covovax, a COVID-19 vaccine domestically produced here by the Serum...

Biocon Biologics, RSSDI collaborate to expand access to insulins for diabetic kids

Ruchika Sharma15 Nov 2021 10:42 AM

Bengaluru: Biocon Biologics Limited, a subsidiary of Biocon Ltd., today announced that it has tied up with the Research Society for the Study of...

Philips, USFDA in talks post new ventilator findings

Ruchika Sharma15 Nov 2021 10:11 AM

Amsterdam: Philips, the medical equipment maker that is recalling ventilators due to use of parts containing a potentially hazardous foam, said on...

AstraZeneca begins to earn mild profit from Covid-19 vaccine

Ruchika Sharma15 Nov 2021 10:07 AM

New Delhi: AstraZeneca said it would begin to earn a modest profit from its coronavirus vaccine as the world learns to live with the virus and the...

Zydus Cadila ZyCov-D to be administered only to adults: Report

Ruchika Sharma15 Nov 2021 10:03 AM

New Delhi: Zydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be...

In talks with multinational pharma firms for brands acquisition: Bafna Pharma

Ruchika Sharma15 Nov 2021 4:30 AM

New Delhi: Pharmaceuticals formulations major Bafna Pharmaceuticals Ltd was in advanced stage of discussion with some multi-national pharma companies...

Philips ventilator recall troubles deepen as USFDA finds new issues

Ruchika Sharma14 Nov 2021 5:15 AM

New Delhi: The U.S. Food and Drug Administration (FDA) has asked Philips to conduct more tests on the foam used in its recalled ventilators,...

EU lists transverse myelitis as side-effect of Johnson and Johnson Covid-19 shot

Ruchika Sharma14 Nov 2021 4:30 AM

New Delhi: Europe's drug regulator on Thursday recommended adding a rare type of spinal inflammation called transverse myelitis as a side-effect of...

Morepen Labs incorporates new step-down subsidiary in mainland Dubai

Morepen Labs net profit up 38 percent at Rs 37 crore in Q2

Ruchika Sharma14 Nov 2021 4:00 AM

New Delhi: Drug firm Morepen Laboratories on Thursday reported a 37.55 per cent rise in its consolidated net profit to Rs 37.36 crore for the quarter...

WHO to set guidelines on COVID antiviral pills soon

Ruchika Sharma14 Nov 2021 3:30 AM

Geneva: World Health Organization (WHO) officials said on Friday they were hoping to convene a meeting soon to set guidelines on the use of COVID-19...

AIMED warns members against supplying medical equipment to AP Govt

Ruchika Sharma13 Nov 2021 7:05 AM

Amaravati: The Association of Indian Medical Device Industry (AIMED) on Friday warned its members against bidding for and supplying any medical...

Zydus Pharma gets USFDA nod for Eluxadoline Tablets

Ruchika Sharma13 Nov 2021 6:30 AM

Ahmedabad: Zydus Cadila today announced that the company's U.S. subsidiary Zydus Pharmaceuticals (USA) Inc. has received tentative approval from the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok